A Six-Month Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Indian Postmenopausal Women With Osteoporosis.
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Registrational; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 21 Nov 2012 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 15 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.